The US media has widely lauded Israel’s vaccine success – as a country in a “post-pandemic future” of concerts and indoor dining; as a country that could teach the United States a few lessons in pandemic management; as a country that, despite being in the midst of a contentious election, leaned on its robust universal public health system to vaccinate as many people as possible. However, many of these vaccine success stories mention the issue of Palestinian vaccines in passing, as an unresolved “controversy,” “debate,” or just another instance of Palestinians and Israelis being unable to agree on anything.
The difference couldn’t be more stark – two populations living under one regime, heading in opposite directions in the struggle with Covid-19. On the Israeli side, we see a country returning to normalcy: a re-opened economy; a vaccination certificate program that allows for entry into gyms, restaurants, and cultural venues; plummeting infection and hospitalization rates; a surplus of vaccinesnearly seven times the small country’s population. On the Palestinian side, minimal vaccines, overwhelmed hospitals, and an economy in crisis. Including the 100,000 Palestinian workers with Israeli work permits that Israel finally agreed to vaccinate in March, Palestinians have received enough vaccines for just over 4% of the 5 million Palestinians living in the occupied West Bank and Gaza Strip.
This Op-ed was published on April 9, 2021 by The Guardian. To read the full op-ed click here.
Yara M. Asi, PhD, is Non-resident fellow at Arab Center Washington DC. To learn more about Yara and read her publications. click here